Human immunodeficiency virus. Human immunodeficiency virus disease
Conditions
Interventions
Intervention 1: CoQ10 200 mg/day for 3 months. Intervention 2: Placebo 200 mg/day for 3 months.
Treatment - Drugs
Placebo
CoQ10 200 mg/day for 3 months
Placebo 200 mg/day for 3 months
Sponsors
Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : HIV-infected adults that HIV confirmed with 2 positive result of ELISA and western blot test and they are in treatment with ART Exclusion criteria: 1- Lymphoma or other malignancies 2- Corticosteroids usage 3- Autoimmune Diseases 4- Advanced Pulmonary Tuberculosis 5- Pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CD4 level. Timepoint: Base line and 3 months after initiation of treatment. Method of measurement: flow cytometry method. | — |
Secondary
| Measure | Time frame |
|---|---|
| ALT. Timepoint: Baseline and 3 months after initiation of treatment. Method of measurement: Device analysis.;AST. Timepoint: Baseline and 3 months after initiation of treatment. Method of measurement: Device analysis.;BUN. Timepoint: Baseline and 3 months after initiation of treatment. Method of measurement: Device analysis.;Cr. Timepoint: Baseline and 3 months after initiation of treatment. Method of measurement: Device analysis.;CBC. Timepoint: Baseline and 3 months after initiation of treatment. Method of measurement: Device analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Roozbeh
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed